Ved mikrosomal enzym- inducerende lægemidler bør der anvendes en ikke- hormonel præventionsmetode under hele den samtidige indgivelse af disse medicinske produkter og i 28 dage efter ophøret hermed.
With microsomal enzyme-inducing medicinal products, the barrier method should be used during the time of concomitant administration of these medicinal products and for 28 days after their discontinuation.